Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 4 |
NetGPI | no | yes: 0, no: 4 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: Q4Q7F7
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 5 |
GO:0006259 | DNA metabolic process | 4 | 5 |
GO:0006308 | DNA catabolic process | 5 | 5 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 5 |
GO:0006807 | nitrogen compound metabolic process | 2 | 5 |
GO:0008152 | metabolic process | 1 | 5 |
GO:0009056 | catabolic process | 2 | 5 |
GO:0009057 | macromolecule catabolic process | 4 | 5 |
GO:0009987 | cellular process | 1 | 5 |
GO:0019439 | aromatic compound catabolic process | 4 | 5 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 5 |
GO:0034655 | nucleobase-containing compound catabolic process | 4 | 5 |
GO:0043170 | macromolecule metabolic process | 3 | 5 |
GO:0044237 | cellular metabolic process | 2 | 5 |
GO:0044238 | primary metabolic process | 2 | 5 |
GO:0044248 | cellular catabolic process | 3 | 5 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 5 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 5 |
GO:0044270 | cellular nitrogen compound catabolic process | 4 | 5 |
GO:0046483 | heterocycle metabolic process | 3 | 5 |
GO:0046700 | heterocycle catabolic process | 4 | 5 |
GO:0071704 | organic substance metabolic process | 2 | 5 |
GO:0090304 | nucleic acid metabolic process | 4 | 5 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 5 |
GO:1901361 | organic cyclic compound catabolic process | 4 | 5 |
GO:1901575 | organic substance catabolic process | 3 | 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 5 |
GO:0003824 | catalytic activity | 1 | 5 |
GO:0004518 | nuclease activity | 4 | 5 |
GO:0004519 | endonuclease activity | 5 | 5 |
GO:0005488 | binding | 1 | 5 |
GO:0016787 | hydrolase activity | 2 | 5 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 5 |
GO:0043167 | ion binding | 2 | 5 |
GO:0043169 | cation binding | 3 | 5 |
GO:0046872 | metal ion binding | 4 | 5 |
GO:0097159 | organic cyclic compound binding | 2 | 5 |
GO:1901363 | heterocyclic compound binding | 2 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 126 | 130 | PF00656 | 0.675 |
CLV_PCSK_FUR_1 | 134 | 138 | PF00082 | 0.483 |
CLV_PCSK_FUR_1 | 175 | 179 | PF00082 | 0.617 |
CLV_PCSK_KEX2_1 | 136 | 138 | PF00082 | 0.483 |
CLV_PCSK_KEX2_1 | 177 | 179 | PF00082 | 0.615 |
CLV_PCSK_PC1ET2_1 | 136 | 138 | PF00082 | 0.483 |
CLV_PCSK_PC1ET2_1 | 177 | 179 | PF00082 | 0.615 |
CLV_PCSK_SKI1_1 | 6 | 10 | PF00082 | 0.522 |
CLV_PCSK_SKI1_1 | 74 | 78 | PF00082 | 0.597 |
DEG_SCF_FBW7_1 | 119 | 126 | PF00400 | 0.675 |
DOC_AGCK_PIF_2 | 59 | 64 | PF00069 | 0.583 |
DOC_MAPK_DCC_7 | 3 | 13 | PF00069 | 0.726 |
DOC_MAPK_gen_1 | 25 | 35 | PF00069 | 0.475 |
DOC_MAPK_gen_1 | 3 | 13 | PF00069 | 0.726 |
DOC_MAPK_MEF2A_6 | 25 | 33 | PF00069 | 0.282 |
DOC_MAPK_MEF2A_6 | 6 | 13 | PF00069 | 0.722 |
DOC_MAPK_NFAT4_5 | 6 | 14 | PF00069 | 0.722 |
DOC_USP7_MATH_1 | 12 | 16 | PF00917 | 0.717 |
DOC_WW_Pin1_4 | 119 | 124 | PF00397 | 0.683 |
LIG_14-3-3_CanoR_1 | 142 | 146 | PF00244 | 0.683 |
LIG_14-3-3_CterR_2 | 175 | 180 | PF00244 | 0.825 |
LIG_APCC_ABBA_1 | 103 | 108 | PF00400 | 0.683 |
LIG_BRCT_BRCA1_1 | 108 | 112 | PF00533 | 0.683 |
LIG_eIF4E_1 | 148 | 154 | PF01652 | 0.683 |
LIG_FHA_2 | 124 | 130 | PF00498 | 0.675 |
LIG_FHA_2 | 89 | 95 | PF00498 | 0.683 |
LIG_FHA_2 | 96 | 102 | PF00498 | 0.595 |
LIG_LIR_Apic_2 | 88 | 93 | PF02991 | 0.683 |
LIG_LIR_Gen_1 | 15 | 23 | PF02991 | 0.709 |
LIG_LIR_Gen_1 | 38 | 49 | PF02991 | 0.489 |
LIG_LIR_Gen_1 | 60 | 67 | PF02991 | 0.583 |
LIG_LIR_Nem_3 | 116 | 121 | PF02991 | 0.683 |
LIG_LIR_Nem_3 | 15 | 20 | PF02991 | 0.722 |
LIG_LIR_Nem_3 | 38 | 42 | PF02991 | 0.538 |
LIG_LIR_Nem_3 | 51 | 57 | PF02991 | 0.339 |
LIG_LIR_Nem_3 | 60 | 65 | PF02991 | 0.425 |
LIG_LYPXL_yS_3 | 118 | 121 | PF13949 | 0.683 |
LIG_NRBOX | 149 | 155 | PF00104 | 0.683 |
LIG_Pex14_2 | 55 | 59 | PF04695 | 0.583 |
LIG_Pex14_2 | 73 | 77 | PF04695 | 0.578 |
LIG_SH2_CRK | 43 | 47 | PF00017 | 0.348 |
LIG_SH2_CRK | 62 | 66 | PF00017 | 0.458 |
LIG_SH2_PTP2 | 39 | 42 | PF00017 | 0.550 |
LIG_SH2_PTP2 | 45 | 48 | PF00017 | 0.510 |
LIG_SH2_SRC | 39 | 42 | PF00017 | 0.542 |
LIG_SH2_SRC | 45 | 48 | PF00017 | 0.447 |
LIG_SH2_STAT5 | 131 | 134 | PF00017 | 0.683 |
LIG_SH2_STAT5 | 152 | 155 | PF00017 | 0.683 |
LIG_SH2_STAT5 | 17 | 20 | PF00017 | 0.729 |
LIG_SH2_STAT5 | 39 | 42 | PF00017 | 0.543 |
LIG_SH2_STAT5 | 45 | 48 | PF00017 | 0.438 |
LIG_SH2_STAT5 | 49 | 52 | PF00017 | 0.368 |
LIG_SH2_STAT5 | 54 | 57 | PF00017 | 0.316 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.683 |
LIG_SH3_3 | 156 | 162 | PF00018 | 0.792 |
LIG_SH3_3 | 31 | 37 | PF00018 | 0.430 |
LIG_SUMO_SIM_anti_2 | 98 | 104 | PF11976 | 0.683 |
LIG_SUMO_SIM_par_1 | 101 | 109 | PF11976 | 0.683 |
LIG_SUMO_SIM_par_1 | 9 | 15 | PF11976 | 0.719 |
LIG_TYR_ITSM | 114 | 121 | PF00017 | 0.683 |
MOD_CK2_1 | 88 | 94 | PF00069 | 0.683 |
MOD_GlcNHglycan | 14 | 17 | PF01048 | 0.563 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.583 |
MOD_GSK3_1 | 119 | 126 | PF00069 | 0.675 |
MOD_N-GLC_1 | 114 | 119 | PF02516 | 0.483 |
MOD_NEK2_1 | 86 | 91 | PF00069 | 0.675 |
MOD_PKA_2 | 141 | 147 | PF00069 | 0.683 |
MOD_Plk_1 | 106 | 112 | PF00069 | 0.683 |
MOD_Plk_1 | 114 | 120 | PF00069 | 0.583 |
MOD_Plk_1 | 164 | 170 | PF00069 | 0.804 |
MOD_Plk_2-3 | 164 | 170 | PF00069 | 0.804 |
MOD_Plk_2-3 | 88 | 94 | PF00069 | 0.683 |
MOD_Plk_4 | 35 | 41 | PF00069 | 0.491 |
MOD_ProDKin_1 | 119 | 125 | PF00069 | 0.683 |
TRG_DiLeu_BaLyEn_6 | 82 | 87 | PF01217 | 0.683 |
TRG_ENDOCYTIC_2 | 118 | 121 | PF00928 | 0.683 |
TRG_ENDOCYTIC_2 | 17 | 20 | PF00928 | 0.743 |
TRG_ENDOCYTIC_2 | 39 | 42 | PF00928 | 0.523 |
TRG_ENDOCYTIC_2 | 43 | 46 | PF00928 | 0.512 |
TRG_ENDOCYTIC_2 | 47 | 50 | PF00928 | 0.412 |
TRG_ENDOCYTIC_2 | 54 | 57 | PF00928 | 0.290 |
TRG_ENDOCYTIC_2 | 62 | 65 | PF00928 | 0.269 |
TRG_NES_CRM1_1 | 94 | 108 | PF08389 | 0.683 |
TRG_Pf-PMV_PEXEL_1 | 97 | 101 | PF00026 | 0.483 |